Development of accurate temperature regulation culture system with metallic culture vessel demonstrates different thermal cytotoxicity in cancer and normal cells

Abstract

Hyperthermia has been studied as a noninvasive cancer treatment. Cancer cells show stronger thermal cytotoxicity than normal cells, which is exploited in hyperthermia. However, the absence of methods evaluating the thermal cytotoxicity in cells prevents the development of hyperthermia. To investigate the thermal cytotoxicity, culture temperature should be regulated. We, thus, developed a culture system regulating culture temperature immediately and accurately by employing metallic culture vessels. Michigan Cancer Foundation-7 cells and normal human dermal fibroblasts were used for models of cancer and normal cells. The findings showed cancer cells showed stronger thermal cytotoxicity than normal cells, which is quantitatively different from previous reports. This difference might be due to regulated culture temperature. The thermal stimulus condition (43 °C/30 min) was, further, focused for assays. The mRNA expression involving apoptosis changed dramatically in cancer cells, indicating the strong apoptotic trend. In contrast, the mRNA expression of heat shock protein (HSP) of normal cells upon the thermal stimulus was stronger than cancer cells. Furthermore, exclusively in normal cells, HSP localization to nucleus was confirmed. These movement of HSP confer thermotolerance to cells, which is consistent with the different thermal cytotoxicity between cancer and normal cells. In summary, our developed system can be used to develop hyperthermia treatment.

Hyperthermia Enhances Efficacy of Chemotherapeutic Agents in Pancreatic Cancer Cell Lines

“…As previously reported [18,54], HT does not impair the cell viability of healthy cells. Heat shock proteins (HSP) have been suggested to play a role in the thermotolerance of the healthy cells [7,51].…”

“…HT can also induce selective tumor cell death when temperatures rise to the supraphysiological range (39-42 • C) [18]. This would be the result of several mechanisms, one of which is the increase in intracellular reactive oxygen species (ROS) [19][20][21][22][23].…”

Electrospun nanofibers for 3-D cancer models, diagnostics, and therapy

“…Hyperthermia is a well-investigated experimental antineoplastic strategy, with tumor cells often prone to increased thermal sensitivity compared to normal tissue. 156 Higher temperature can render cells more susceptible to killing by approaches including chemotherapy, radiotherapy, and immunotherapy, and hyperthermia may act as a synergistic adjunct or sensitizer to the effects of concurrent drug release. [157][158][159] While magnetic nanoparticle-based inductive hyperthermia is a highly promising technique, nanoparticle delivery confronts many of the same obstacles as conventional drug delivery, including the need to sustain nanoparticle concentration at the target site, while preventing fast recognition/elimination by the reticuloendothelial and immune systems.…”

Multifunctional Nanocarriers of Fe 3 O 4 @PLA-PEG/Curcumin for MRI, Magnetic Hyperthermia and Drug Delivery

“…Probably, one of the most attractive properties of MNPs is the so-called magnetic fluid hyperthermia (MFH), which is based on their capability to adsorb energy from an alternating magnetic field (AMF) to generate heat via their Néel and/or Brownian relaxation dissipation [11,22]. When inserted into tumor tissues, MNPs can kill cancer cells by increasing the local temperature, because cancer cells show stronger thermal cytotoxicity than normal cells [23]. Therefore, MNPs have been intensively studied for their use as potential MFH agents in cancer treatment [24][25][26].…”